|
2025-05-19 |
2025-05-16 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
1 929
-0.7%
8,89
17 149 USD
|
1 929
-0.7%
|
8,89
|
17 149 USD
|
|
|
2025-05-05 |
2025-05-01 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
68 412
-5.1%
7,35
502 828 USD
|
68 412
-5.1%
|
7,35
|
502 828 USD
|
|
|
2025-03-26 |
2025-03-24 |
VP
Vente planifiée
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
1 698
-0.1%
9,00
15 282 USD
|
1 698
-0.1%
|
9,00
|
15 282 USD
|
|
|
2025-03-17 |
2025-03-13 |
V
Vente
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
36 291
-70.2%
7,19
260 932 USD
|
36 291
-70.2%
|
7,19
|
260 932 USD
|
|
|
2025-03-12 |
2025-03-12 |
V
Vente
|
HERSHBERG ROBERT
Administrateur non-exécutif
|
53 000
-43.2%
7,59
402 270 USD
|
53 000
-43.2%
|
7,59
|
402 270 USD
|
|
|
2025-03-12 |
2025-03-10 |
V
Vente
|
NEUPERT PETER M
Administrateur non-exécutif
|
10 000
-4.3%
7,05
70 500 USD
|
10 000
-4.3%
|
7,05
|
70 500 USD
|
|
|
2025-03-06 |
2025-03-06 |
VP
Vente planifiée
|
GRIFFIN MICHELLE RENEE
Administrateur non-exécutif
|
15 664
-23.3%
7,94
124 372 USD
|
15 664
-23.3%
|
7,94
|
124 372 USD
|
|
|
2025-03-06 |
2025-03-06 |
V
Vente
|
ROBINS CHAD M
CEO and Chairman
Administrateur exécutif
|
102 218
-3.3%
7,64
780 946 USD
|
102 218
-3.3%
|
7,64
|
780 946 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
13 790
-4.0%
6,99
96 392 USD
|
13 790
-4.0%
|
6,99
|
96 392 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
LO FRANCIS
Chief People Officer
Dirigeant
|
7 085
-2.0%
6,98
49 453 USD
|
7 085
-2.0%
|
6,98
|
49 453 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Dirigeant
|
26 023
-7.0%
6,98
181 641 USD
|
26 023
-7.0%
|
6,98
|
181 641 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
6 964
-2.5%
6,99
48 678 USD
|
6 964
-2.5%
|
6,99
|
48 678 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
253
-0.1%
6,98
1 766 USD
|
253
-0.1%
|
6,98
|
1 766 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
PISKEL KYLE
Chief Financial Officer
Dirigeant
|
3 103
-1.1%
6,97
21 628 USD
|
3 103
-1.1%
|
6,97
|
21 628 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
3 065
-0.8%
6,99
21 424 USD
|
3 065
-0.8%
|
6,99
|
21 424 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
Dirigeant
|
41 600
-9.5%
6,98
290 368 USD
|
41 600
-9.5%
|
6,98
|
290 368 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
RUBINSTEIN JULIE
President and COO
Dirigeant
|
19 461
-3.2%
6,99
136 032 USD
|
19 461
-3.2%
|
6,99
|
136 032 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
RUBINSTEIN JULIE
President and COO
Dirigeant
|
40 044
-6.2%
6,98
279 507 USD
|
40 044
-6.2%
|
6,98
|
279 507 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
56 053
-4.2%
6,99
391 810 USD
|
56 053
-4.2%
|
6,99
|
391 810 USD
|
|
|
2025-03-06 |
2025-03-05 |
V
Vente
|
ROBINS HARLAN S
Chief Scientific Officer
Dirigeant
|
40 603
-3.0%
6,98
283 409 USD
|
40 603
-3.0%
|
6,98
|
283 409 USD
|
|
